B-lymphocytic leukemia, chronic

Clinical trials for B-lymphocytic leukemia, chronic explained in plain language.

Never miss a new study

Get alerted when new B-lymphocytic leukemia, chronic trials appear

Sign up with your email to follow new studies for B-lymphocytic leukemia, chronic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

New cocktail aims to tackle tough leukemia

Disease control Completed

This phase II study tested a combination of three drugs—ibrutinib, fludarabine, and pembrolizumab—in 15 people with high-risk or relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see if the combo could produce a complete r…

Matched conditions: B-LYMPHOCYTIC LEUKEMIA, CHRONIC

Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

B-lymphocytic leukemia, chronic

Get alerted when new B-lymphocytic leukemia, chronic trials appear

New cocktail aims to tackle tough leukemia